Platelet Function Testing to Guide Cangrelor Dosing in Patients with Temporary Mechanical Circulatory Support or as a Bridge to Procedure

Cangrelor is a rapid-acting, intravenous P2Y12 inhibitor that can be used in patients after percutaneous coronary intervention who require mechanical circulatory support or as a bridge to procedure. We retrospectively reviewed adult patients who received platelet function testing (PFT) with the Veri...

Full description

Bibliographic Details
Published in:	Clinical and Applied Thrombosis/Hemostasis
Main Authors:	Margaret M. Buck PharmD, Chelsea I. Barry PharmD, Courtney A. Montepara PharmD, Nathan J. Verlinden PharmD
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-03-01
Online Access:	https://doi.org/10.1177/10760296241237228

Similar Items

Evaluation of the tacrolimus drug interaction with voriconazole vs clotrimazole in heart transplant recipients
by: Elizabeth Posney, PharmD, et al.
Published: (2024-05-01)

Implementation of a practice model for inpatient psychiatric clinical pharmacist practitioners with prescriptive authority at a veterans health care facility
by: Chinedu Diokpa, PharmD, et al.
Published: (2024-08-01)

Impact of traditional versus nontraditional initiation dosing schedule of paliperidone palmitate on 30-day readmission and safety
by: Erika Kim, PharmD, BCPP, et al.
Published: (2023-12-01)

Knowledge, Attitude and Practice Related to Chemotherapy Among Cancer Patients
by: Muzna Suhail MPhil, et al.
Published: (2024-04-01)

Hemodynamic Effects of an Increased Midodrine Dosing Frequency
by: Shea A. Macielak, PharmD, et al.
Published: (2021-04-01)

Microdose induction of buprenorphine-naloxone in a patient using high dose methadone: A case report
by: Menard Shannon PharmD, et al.
Published: (2021-11-01)

Alternatives to Hydrocortisone for Hemodynamic Support in Septic Shock Management Due to Medication Shortage
by: Mohammed Aldhaeefi, PharmD, et al.
Published: (2023-07-01)

Derivation and Validation of Age- and Body Mass Index-Adjusted Weight-Based Unfractionated Heparin Dosing
by: James W. Schurr PharmD, et al.
Published: (2019-03-01)

Review of acamprosate pharmacokinetics and dosing strategies
by: Lauren Steil, PharmD, et al.
Published: (2025-04-01)

Clinical strategies for low-dose overlap initiation of buprenorphine and potential barriers to use
by: Austin Smith, PharmD, BCPP, et al.
Published: (2025-10-01)

Adverse childhood experiences among California student pharmacists
by: Shawn R. Smith, PharmD, APh, et al.
Published: (2024-02-01)

Comparison of Fixed Versus Weight-Based Prothrombin Complex Concentrate Dosing Strategies for Factor Xa Inhibitor Reversal
by: Snyder Brett PharmD, et al.
Published: (2024-05-01)

Comparison of clozapine doses and tolerability in patients with and without concurrent valproic acid
by: Ranel Troy Santos, PharmD, BCPP, et al.
Published: (2023-01-01)

Belatacept Removal by Plasmapheresis: Dose Adjustments and Clinical Recommendations
by: Nicole K. Wilson, PharmD, MS, BCTXP, et al.
Published: (2024-08-01)

Outcomes Associated with Time in Therapeutic Range for Patients Receiving Intravenous Unfractionated Heparin
by: Mujtaba Mahmud PharmD, et al.
Published: (2025-08-01)

Assessing intradisciplinary pharmacy communication related to transitions of care
by: Letitia N. Warunek, PharmD, BCPS, et al.
Published: (2024-06-01)

Pharmacologic management of adolescent catatonia: A dual-case series
by: Lauren Leiby, PharmD, BCPP, et al.
Published: (2024-06-01)

Retrospective Analysis of Medication Adherence and Cost Following Medication Therapy Management
by: Ashley Branham, PharmD, et al.
Published: (2010-01-01)

Evaluation of the Clinical Outcomes of Apixaban Use in Patients with Atrial Fibrillation and Uncontrolled Hypothyroidism: A Real-world Evidence
by: Khalid Al Sulaiman BCCCP, BCNSP, MBA, FCCM, et al.
Published: (2025-09-01)

Efficacy of Berberine Alone and in Combination for the Treatment of Hyperlipidemia: A Systematic Review
by: Laura M. Koppen PharmD, et al.
Published: (2017-10-01)

Clinical Characteristics and Outcomes of Deep Vein Thrombosis in Relation to Location: A Retrospective Analysis Study
by: Majed S. Al Yami PharmD, et al.
Published: (2025-01-01)

Ultrasound-Assisted Catheter-Directed Thrombolysis for the Management of Pulmonary Embolism:
by: Jasmine Ventenilla PharmD, et al.
Published: (2024-02-01)

Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review
by: Tressa McMorris, PharmD, BCPS, et al.
Published: (2021-07-01)

Intranasal esketamine use in bipolar disorder: A case report
by: Courtney Skriptshak, PharmD, et al.
Published: (2021-07-01)

Unlocking the therapeutic capabilities of GPCR in the treatment of ischemic stroke: A translational literature
by: Girish B S, Pharm.D, et al.
Published: (2024-12-01)

191 Pharmacist Empowerment, Mandatory 4T Scoring and Real-time EHR Alerts to Optimize Antithrombosis Stewardship Around Diagnosis and Management of Heparin Induced Thrombocytopenia: The Persistent Study
by: Shruti N. Karanth, PharmD, et al.
Published: (2025-05-01)

Abuse liability of gabapentin in the Saudi population after the pregabalin restriction: A cross-sectional study
by: Amina A. Alkhalaf, PharmD, et al.
Published: (2021-10-01)

Comparison of long-acting injectable antipsychotics with oral antipsychotics and hospital readmission rates in pediatric patients
by: Danial Chowdhury, PharmD, et al.
Published: (2024-04-01)

Evaluation of the use of chlorpromazine for agitation in pediatric patients
by: Rajwoana Ahmed, PharmD, et al.
Published: (2023-03-01)

Evaluating the Efficacy and Safety of Direct Oral Anticoagulants Compared to Vitamin K Antagonists in Patients with Antiphospholipid Syndrome: Updated Systematic Review and Meta-Analysis
by: Lama Alfehaid PharmD, MME, et al.
Published: (2025-08-01)

The use of the ketogenic diet in the treatment of psychiatric disorders
by: Erika E. Tillery, PharmD, et al.
Published: (2021-05-01)

Stewardship applied to antipsychotics: Development of an antipsychotic stewardship program in inpatient settings for monitoring and optimizing outcomes
by: Gillian Gonzales, PharmD, et al.
Published: (2022-11-01)

Implementation and evaluation of interprofessional overdose review team recommendations following intentional or accidental overdose events
by: Monica Barrett, PharmD, BCPP, et al.
Published: (2024-06-01)

“It’s been a long time since I drank like that”: A case report of binge drinking associated with aripiprazole
by: Alyssa Falleni, PharmD, et al.
Published: (2024-06-01)

Social Media and Unprofessional Pharmacist Conduct: A Cross-Sectional Survey of Boards of Pharmacy
by: Lindsey Elmore, PharmD, BCPS, et al.
Published: (2013-01-01)

Impact of psychiatric pharmacist-led ambulatory alcohol withdrawal management
by: Maxwell Lamb, PharmD, BCPS, et al.
Published: (2025-06-01)

COVID-19 reinfection in a patient with a serious mental illness within a long-term inpatient psychiatric care hospital
by: Brianna Englett, PharmD, BCPP, et al.
Published: (2021-09-01)

Evaluating the impact of an emergency department protocol that guides management of methamphetamine-induced agitation and psychosis
by: Julie Nguyen, PharmD, et al.
Published: (2022-01-01)

A case report and literature review of olanzapine-associated hyperglycemia with previous history of gestational diabetes
by: Jennifer N. Alastanos, PharmD, BCPP, BCPS, et al.
Published: (2022-01-01)

Effect of cannabis use on PTSD treatment outcomes in veterans
by: Meagan Petersen, PharmD, BCPP, et al.
Published: (2021-07-01)